Advisory Research’s BEXIL CRP BXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-38,885
Closed -$263K 273
2016
Q2
$263K Sell
38,885
-10,848
-22% -$73.4K ﹤0.01% 237
2016
Q1
$385K Sell
49,733
-1,530
-3% -$11.8K 0.01% 228
2015
Q4
$397K Hold
51,263
0.01% 247
2015
Q3
$436K Hold
51,263
0.01% 262
2015
Q2
$398K Sell
51,263
-24,495
-32% -$190K ﹤0.01% 296
2015
Q1
$682K Sell
75,758
-1,305
-2% -$11.7K 0.01% 277
2014
Q4
$917K Sell
77,063
-11,137
-13% -$133K 0.01% 262
2014
Q3
$1.41M Hold
88,200
0.01% 229
2014
Q2
$1.81M Hold
88,200
0.02% 210
2014
Q1
$2.12M Hold
88,200
0.02% 186
2013
Q4
$2.83M Hold
88,200
0.03% 180
2013
Q3
$4.15M Hold
88,200
0.04% 172
2013
Q2
$5.29M Buy
+88,200
New +$5.29M 0.06% 168

Advisory Research's BXL Position: Q3 2016 in Review

Advisory Research sold out of BEXIL CRP (BXL) in Q3 2016, closing a stake of 38,885 shares — an estimated $263K sold.

Advisory Research first reported a position in BXL in Q2 2013 and held it in 13 quarters. The position peaked at $5.29M in Q2 2013. 0 funds tracked by Wall St. Rank hold BXL as of Q3 2016.

  • Advisory Research reported no remaining BEXIL CRP position as of Q3 2016 after selling out during the quarter.
  • Advisory Research sold 38,885 BEXIL CRP shares in Q3 2016, an estimated $263K.
  • Advisory Research first reported a position in BEXIL CRP in Q2 2013 and held it in 13 quarters.
  • Advisory Research's BEXIL CRP position peaked at $5.29M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held BEXIL CRP as of Q3 2016.

Based on Advisory Research's 13F filing for Q3 2016, filed 14 Nov 2016.